Canada's eight-step vaccine safety program: Vaccine literacy

Paediatrics and Child Health

Volumn 14, Issue 9, 2009, Pages 605-608

  MacDonald, N ^a   Pickering, L ^a  

^a CANADIAN PAEDIATRIC SOCIETY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

CANADA; DRUG APPROVAL; DRUG EFFICACY; DRUG MANUFACTURE; DRUG SAFETY; DRUG USE; HUMAN; IMMUNIZATION; NOTE; POSTMARKETING SURVEILLANCE; PUBLIC HEALTH PROBLEM; UNSPECIFIED SIDE EFFECT; VACCINATION;

EID: 73949101133     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/14.9.605     Document Type: Note

References (16)

1. Fisher MC. Vaccine safety. Pediatr Infect Dis J 2008;27:827-30.
2. Jagessar N, Lazarus JV, Matic S, Emiroglu N. Immunization: Mind the gap. Vaccine 2008;26:6736-7.
3. Centers for Disease Control and Prevention. Invasive Haemophilus influenzae Type B disease in five young children - Minnesota, 2008. MMWR Morb Mortal Wkly Rep 2009;58:58-60.
4. Scheifele DW, Bettinger JA, Halperin SA, Law B, Bortolussi R. Ongoing control of Haemophilus influenzae Type B infections in Canadian children, 2004-2007. Pediatr Infect Dis J 2008;27:755-7.
5. Centers for Disease Control and Prevention. Update: Measles - United States, January-July 2008. MMWR Morb Mortal Wkly Rep 2008;57:893-6.
6. MacDonald NE, Halperin B, Chaple EB, Scott J, Kirk JM. Infectious disease management: Lessons from Cuba. Can J Infect Dis Med Microbiol 2006;17:217-20.
7. National Advisory Committee on Immunization. Canadian Immunization Guide, Seventh Edition. Public Health Agency of Canada, 2006:59-72. 〈www.phac-aspc.gc.ca/publicat/cig-gci/index-eng.php〉 (Version current at August 18, 2009).
8. Chen RT, Rastogi SC, Mullen JR, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994;12:542-50.
9. Scheifele D. IMPACT after 17 years: Lessons learned about successful networking. Paediatr Child Health 2009;14:33-5.
10. Centers for Disease Control and Prevention. Vaccine Safety Datalink (VSD) Project. 〈www.cdc.gov/vaccinesafety/Activities/VSD.html〉 (Version current at August 18, 2009).
11. Yih WK, Nordin JD, Kulldorff M, et al. An assessment of the safety of adolescent and adult tetanusdiphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine 2009;27:4257-62.
12. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine - United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999;48:577-81.
13. Centers for Disease Control and Prevention. Postmarketing monitoring of intussusception after RotaTeq vaccination - United States, February 1, 2006-February 15, 2007. MMWR Morb Mortal Wkly Rep 2007;56:218-22.
14. Health Canada. Three Lots of Measles, Mumps and Rubella Vaccine Suspended from Use. 〈www.hcsc. gc.ca/ahc-asc/media/advisories-avis/-2007/2007-169- eng.php〉 (Version current at August 18, 2009).
15. Collet JP, MacDonald N, Cashman N, Pless R. Monitoring signals for vaccine safety: The assessment of individual adverse event reports by an expert advisory committee. Advisory Committee on Causality Assessment. Bull World Health Organ 2000;78:178-85.
16. Folb PI, Bernatowska E, Chen R, et al. A global perspective on vaccine safety and public health: The Global Advisory Committee on Vaccine Safety. Am J Public Health 2004;94:1926-31.